Jonathan Wolleben

Stock Analyst at JMP Securities

(4.10)
# 455
Out of 4,853 analysts
195
Total ratings
46.77%
Success rate
13.43%
Average return

Stocks Rated by Jonathan Wolleben

DBV Technologies
May 27, 2025
Maintains: Market Outperform
Price Target: $15$21
Current: $8.51
Upside: +146.77%
Aura Biosciences
May 23, 2025
Reiterates: Market Outperform
Price Target: $19
Current: $6.10
Upside: +211.48%
Clearside Biomedical
May 16, 2025
Reiterates: Market Outperform
Price Target: $5
Current: $0.78
Upside: +545.16%
Mirum Pharmaceuticals
May 9, 2025
Maintains: Market Outperform
Price Target: $74$76
Current: $44.65
Upside: +70.21%
Madrigal Pharmaceuticals
Apr 24, 2025
Reiterates: Market Outperform
Price Target: $443
Current: $274.10
Upside: +61.62%
MBX Biosciences
Apr 10, 2025
Initiates: Market Outperform
Price Target: $38
Current: $11.86
Upside: +220.40%
Altimmune
Apr 2, 2025
Reiterates: Market Outperform
Price Target: $25
Current: $5.46
Upside: +357.88%
KalVista Pharmaceuticals
Mar 26, 2025
Reiterates: Market Outperform
Price Target: $19
Current: $13.80
Upside: +37.68%
Skye Bioscience
Mar 21, 2025
Reiterates: Market Outperform
Price Target: $15
Current: $2.15
Upside: +597.67%
Protagonist Therapeutics
Mar 10, 2025
Reiterates: Market Outperform
Price Target: $61
Current: $53.82
Upside: +13.34%
Maintains: Market Outperform
Price Target: $22$19
Current: $8.46
Upside: +124.59%
Reiterates: Market Outperform
Price Target: $55
Current: $16.23
Upside: +238.98%
Reiterates: Market Outperform
Price Target: $18
Current: $10.98
Upside: +63.93%
Reiterates: Market Outperform
Price Target: $26
Current: $5.22
Upside: +398.08%
Maintains: Market Outperform
Price Target: $91$87
Current: $21.47
Upside: +305.22%
Maintains: Market Outperform
Price Target: $92$91
Current: $32.29
Upside: +181.82%
Reiterates: Market Outperform
Price Target: $75
Current: $66.18
Upside: +13.33%
Reiterates: Market Outperform
Price Target: $9
Current: $2.38
Upside: +278.15%
Maintains: Market Outperform
Price Target: $55$50
Current: $39.03
Upside: +28.11%
Reiterates: Market Outperform
Price Target: $90
Current: $78.20
Upside: +15.09%
Reiterates: Market Perform
Price Target: n/a
Current: $137.29
Upside: -
Reiterates: Market Outperform
Price Target: $8
Current: $1.80
Upside: +344.44%
Downgrades: Accumulate
Price Target: $420$485
Current: $712.82
Upside: -31.96%
Maintains: Market Outperform
Price Target: $48$32
Current: $4.78
Upside: +569.46%
Reiterates: Market Outperform
Price Target: $25
Current: $2.46
Upside: +916.26%
Reiterates: Market Outperform
Price Target: $8
Current: $0.34
Upside: +2,258.49%
Maintains: Outperform
Price Target: $25$24
Current: $26.21
Upside: -8.43%